Oestrogen receptor content and cancer cell/stroma ratio in mammary carcinoma. 1988

M Helle, and H Helin, and J Isola, and K Krohn
Mikkeli Central Hospital, Finland.

In a study of 86 human breast cancers the volume fraction of the neoplastic epithelium was estimated semiquantitatively and a significant association was found between the oestrogen receptor (ER) content and volume fraction of cancer cells of tumours (p less than 0.00001). Tumours with very low cellularity could thus be falsely ER negative. When quantitative ER concentration is used to predict the response of tumours to hormonal therapy the cellularity of tumours should be taken in consideration. The cellularity was not related to ER positivity. Although a correlation was seen between the contents of oestrogen and progesterone (PR) receptors, no correlation between PR content and volume fraction of the neoplastic epithelium was observed.

UI MeSH Term Description Entries
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Helle, and H Helin, and J Isola, and K Krohn
April 2014, British journal of cancer,
M Helle, and H Helin, and J Isola, and K Krohn
May 2015, British journal of cancer,
M Helle, and H Helin, and J Isola, and K Krohn
September 1983, European journal of cancer & clinical oncology,
M Helle, and H Helin, and J Isola, and K Krohn
January 1981, Virchows Archiv. A, Pathological anatomy and histology,
M Helle, and H Helin, and J Isola, and K Krohn
October 1974, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
M Helle, and H Helin, and J Isola, and K Krohn
March 1975, The Journal of endocrinology,
M Helle, and H Helin, and J Isola, and K Krohn
August 1990, Journal of clinical pathology,
M Helle, and H Helin, and J Isola, and K Krohn
May 2015, British journal of cancer,
M Helle, and H Helin, and J Isola, and K Krohn
November 1989, Journal of clinical pathology,
M Helle, and H Helin, and J Isola, and K Krohn
July 1979, Cancer,
Copied contents to your clipboard!